NEW ZEALAND GAZETTE, No. 49 — 8 MAY 2015

(c) a combination of L-amino acids and the hydrolysate of one or more of the proteins on which infant formula product is normally based.

soy-based formula means an infant formula product in which soy protein isolate is the sole source of protein.

2.9.1—4 Interpretation

Interpretation of compositional requirements

(1) Compositional requirements in this Standard apply to:

(a) a powdered or concentrated form of infant formula product that has been reconstituted with water according to directions; or

(b) an infant formula product in ‘ready to drink’ form.

Calculation of energy, protein and potential renal solute load

(2) In this Standard:

(a) energy must be calculated in accordance with section S29—2; and

(b) protein content must be calculated in accordance with the equation set out in section S29—3; and

(c) potential renal solute load must be calculated in accordance with section S29—4.

Division 2 General compositional requirements for infant formula products

2.9.1—5 Use of substances as nutritive substances

Use of nutritive substances

(1) A substance listed in Column 1 of the table to section S29—5 may be *used as a nutritive substance in an infant formula product only if:

(a) it is in a permitted form listed in Column 2 of the table; and

(b) the amount of the substance in the product (including any naturally-occurring amount) is no more than the corresponding amount listed in Column 4 of the table.

Labelling of nutritive substances

(2) For the labelling provisions, a label may include words or other indications to the effect that the product contains a substance that is listed in Column 1 or Column 2 of the table to section S29—5 only if the amount of the substance in the product (including any naturally-occurring amount) is at least the corresponding amount listed in Column 3 of that table.

Note The labelling provisions are set out in Standard 1.2.1.

2.9.1—6 Addition of lactic acid producing microorganisms

L(+) lactic acid producing microorganisms may be added to infant formula product.

2.9.1—7 Permitted quantities of added inulin-type fructans and galacto-oligosaccharides

If an inulin-type fructan or a galacto-oligosaccharide is added to an infant formula product, the product must contain (taking into account both the naturally-occurring and added substances) no more than:

(a) if only *inulin-type fructans are added—110 mg/100 kJ of inulin-type fructans; or

(b) if only *galacto-oligosaccharides are added—290 mg/100 kJ of galacto-oligosaccharides; or

(c) if both inulin-type fructans and galacto-oligosaccharides are added:

(i) no more than 110 mg/100 kJ of inulin-type fructans; and

(ii) no more than 290 mg/100 kJ of combined inulin-type fructans and galacto-oligosaccharides.

2.9.1—8 Restriction on levels of other substances in infant formula product

Infant formula product must not contain:

(a) detectable gluten; or

(b) more than 3.8 mg/100 kJ of nucleotide-5′-monophosphates; or

(c) more than the following amounts of aluminium:

(i) for a pre-term formula—0.02 mg/100 mL;

(ii) for a soy-based formula—0.1 mg/100 mL;

(iii) otherwise—0.05 mg/100 mL.

Note Standard 1.4.1 contains the maximum level (ML) of lead contaminant in infant formula products.

Division 3 Infant formula and follow-on formula